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ABSTRACT  
          Solid dispersions (SDs) of modafinil (MDF) were prepared 
using polyethyleneglycols (PEGs), in 1;1, 1;2 and 1;4 proportions 
by fusion, solvent evaporation and physical mixing method. 
Differential scanning calorimetry (DSC) and X-ray powder 
diffractometry (XRD) were used to examine the physical state of 
the drug. The data from the XRD showed that the drug was 
converted to amorphous form as the number and intensity of 
peaks were decreased in solid dispersion as compared to pure 
drug and physical mixture of drug and carrier. DSC thermograms 
also confirmed the change in physical state of the drug as the 
peaks were altered or disappeared. With the highest ratio of the 
carriers (1:4), the drug solubility was enhanced by 38.68, 34.78 
and 9.29 folds in solvent evaporation, fusion and physical mixing 
methods respectively. Solid dispersion batch S6 containing 
drug:PEG6000 in 1:4, was selected to be formulated as tablet 
(batch TS6) and evaluated for in vitro drug dissolution & six 
month stability. An increased dissolution rate of modafinil was 
observed from SDs and PMs, as compared to pure crystalline 
drug. The dissolution rate of modafinil from its PMs or SDs 
increased with an increasing amount of polymer. 
 




Many potential drug candidates are 
characterized by a low oral bioavailability. 
Often, poor drug dissolution/solubility rather 
than limited permeation through the epithelia 
of the gastrointestinal tract are responsible for 
low oral bioavailability. The relationship 
between dissolution rate and absorption is 
particularly distinct when considering drugs of 
low solubility. Consequently, numerous 
attempts have been made to modify the 
dissolution characteristics of certain drugs in an 
effort to attain more rapid and more complete 
absorption.  
Among the techniques to increase 
aqueous solubility/dissolution rate, the 
formulation of solid dispersions is one of the 
most popular ones (Chiou et al., 1971; Ford et 
al., 1986), although few marketed products rely 
on this concept. The interest in amorphous 
drug–polymer solid dispersions has grown due 
to the potential of improving bioavailability, 
particularly for poorly water-soluble drugs 
(Leuner et al., 2000; Craig et al., 2002; Hancock 
et al., 2002). The basis for this interest stems 
from the increased rate of dissolution, which 
can range from hundreds to thousands fold 
increase, even for the most insoluble active 
pharmaceutical ingredients (Hancock et al., 
2002). For drugs whose bioavailability is limited 
due to poor aqueous solubility (as in BSC class 
II drugs), the improvement in solubility may 
lead to enhanced bioavailability (Ahuja et al., 
2007; Vippagunta et al., 2007; Ambike et al., 
2005). The SDs of drugs with PEGs may be 
useful to solve various problems such as 
stability, solubility, dissolution and bio-
availability (Khawam et al., 2006; Marsac et al., 
2006a; Marsac et al., 2006b).  
Solid dispersion represents a useful 
pharmaceutical technique for increasing the 
dissolution, absorption, and therapeutic efficacy 
of drugs in dosage forms (Mayersohn et al., 
1966; Chiou et al., 1969). The properties, 
performance, and practical applications of solid 
dispersions depend on factors such as: (a) the 
method of preparation, (b) composition, (c) 
selection of a suitable carrier, and (d) 
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physicochemical properties of the drug (Chiou 
et al., 1971, Hajratwala et al., 1974).  
Modafinil is approved by the USFDA 
for the treatment of narcolepsy, hypersomnia, 
shift work sleep disorder and excessive daytime 
sleepiness associated with obstructive sleep 
apnoea and in adult it is used in attention 
deficient/hyperactivity disorder (ADHD). It is 
rapidly absorbed after oral administration with 
peak plasma concentrations occurring at 2-4 
hours. But the oral bioavailability of the drug is 
very poor due to water insolubility (Minzenberg 
et al., 2007, Jacobs et al., 2002). Modafinil is 
BCS class II drug; hence improvement of 
dissolution will lead to enhancement of 
bioavailability.  
The primary objective of the present 
study is to investigate the possibility of 
improving the release properties of modafinil 




Modafinil was obtained as a gift sample 
from Alembic Pharmaceuticals Ltd. (Vadodara, 
India); PEG2000, PEG10000, acetone and 
chloroform were purchased from S.D. Fine 
Chemicals Ltd. (Mumbai, India); hydrochloric 
acid was purchased from Loba Chem (Mumbai, 
India). Tablet excipients like, crosspovidone, 
Avicel pH101, StaRx1500, MCC and Ac-Di-Sol 
were purchased from S.D. Fine Chemicals Ltd. 
(Mumbai, India). Distilled water was freshly 
prepared and used for the study. All the 
chemicals and reagents were of Analytical 
Reagent (AR) grade and used without further 
purifications. 
 
Preparation of solid dispersions 
Solid dispersions were prepared by three 
different methods i.e. fusion, solvent 
evaporation and physical mixing method 
Fusion method: Solid dispersions 
containing different weight ratios (1:1, 1:2, 1:4) 
of drug in PEG2000, PEG6000, and 
PEG10000 were prepared by melting the 
carriers in porcelain dish (at around 100º C 
more than the melting point of carriers on sand 
bath), dispersing the drug onto the molten 
carrier and cooling immediately on freezing 
mixture of ice and sodium chloride. The solid 
dispersions were then allowed to cool at an 
ambient temperature and stored in desiccators 
for 24 hours. The dry mass was scrapped, 
crushed & ground in a mortar and passed 
through sieve #40. The dried mass was stored 
in desiccator until further use.  
Solvent evaporation method: Solid 
dispersions containing different weight ratios 
(1:1, 1:2, 1:4) of drug in PEG2000, PEG6000, 
and PEG10000 were prepared by dissolving 
required amount of drug and carriers in solvent 
system containing acetone and chloroform in 
1:1 proportion. The solvent was evaporated at 
40° C on water bath with continuous stirring 
and the resulting residues were dried under 
vacuum for 3 hours and stored in desiccators 
for overnight. The dry mass was ground in a 
mortar, passed through sieve #40 and stored in 
desiccator until further use.  
Physical mixing: Drug and carriers were 
blended in desired proportions using spatula 
for 10 minutes and then ground in mortar with 
pestle. The co-grinding mixture was then 
passed through sieve #40 and stored in 
desiccator until further use. 
 
Characterisation of solid dispersions 
containing modafinil 
Saturation solubility: The saturation 
solubility of drug, carriers and all the solid 
dispersions was determined by dispersing 1g of 
drug, carrier or solid dispersion into 100mL of 
distilled water contained in glass bottle and 
shaken for not less than 24 hours. Solubility 
was then determined in mg/mL using 
spectrophotometer (Shimadzu 1700, Japan) 
with λmax at 222nm after filtration (through a 
0.45μm Millipore filter) and necessary dilutions.  
Melting point: Melting point of drug, 
polymer and all the solid dispersions was 
determined using precision melting point 
apparatus (Shimadzu MP09, Japan). Two 
samples were tested at a time by placing a 
pintch of sample into the capillary and heating 
at slow and consistent rate. 
Stability: The prepared solid dispersions 
were stored in stability chamber at 45 + 2º C 
with 75% RH for 6 months. The formulations 
were analysed for one point in vitro dissolution, 
solubility and melting point after 6 months and 
compared with the results obtained with 
formulations prepared and analysed 
immediately. 
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Differential Scanning Calorimetry (DSC) 
Analysis: DSC scans of the powdered samples 
were recorded using DSC- 822e Mettler Toledo 
with the Stare software. All the samples were 
weighed (4-5 mg) and heated for total time of 
40 min at a scanning rate of 5° C/min under 
dry air (N2) flow (50 mL/min) at pressure of 25 
psi between 50 and 250° C (furnace 
temperature). Aluminium pans and lids (40μL 
capacity) were used for the study. 
X-ray diffraction analysis: X-ray diffraction 
(XRD) patterns were recorded on an X-
diffractometer (Phillip PW 1130/00 
diffractometer, Natherland), employing CuK∞ 
radiation source operating at 30 mA and 40 kV. 
Samples were scanned from 6 to 40° 2θ at a 
scanning rate of 0.02° 2θ s-1.  
 
 
Preparation and evaluation of tablets 
containing modafinil 
Tablets containing either solid 
dispersions, drug-carrier physical mixture or 
simple drug equivalent to 100mg of modafinil 
were prepared by direct compression method 
after mixing with required amount of different 
ingredients as shown in table III. All the 
prepared tablets were subjected to routine 
quality control tests like hardness, friability and 
weight variation before evaluating for in vitro 
dissolution and stability study. 
In vitro dissolution study: In vitro 
dissolution study of modafinil was perfor-        
med on 8 vessel USP type II dissolution                      
test apparatus in 0.1N HCl with constant 
temperature   37+2°  C    and    speed    50rpm.  
Table I. Composition of solid dispersions prepared different methods 
 
Method Modafinil (mg) PEG 2000 (mg) PEG 6000 (mg) PEG 10000 (mg) 
100 F1/100 F4/100 F7/100 
100 F2/200 F5/200 F8/200 
Fusion 
method 
100 F3/400 F6/400 F9/400 
100 S1/100 S4/100 S7/100 
100 S2/200 S5/200 S8/200 
Solvent 
evaporation 
method 100 S3/400 S6/400 S9/400 
100 P1/100 P4/100 P7/100 
100 P2/200 P5/200 P8/200 
Physical 
mixtures 
100 P3/400 P6/400 P9/400 
 
F1-F9, S1-S9 and P1-P9 are the batches prepared by Fusion method, Solvent evaporation method and 
simple mixing.  
 
Table II. Characterization of solid dispersions prepared different methods 
 
Fusion method Solvent evaporation method Physical mixtures 
Batch SS MP (°C) Batch SS MP (°C) Batch SS MP (°C) 
F1 1.13 135 S1 1.25 127 P1 0.43 164 
F2 1.25 132 S2 1.40 124 P2 0.47 162 
F3 1.57 130 S3 1.75 121 P3 0.59 161 
F4 1.51 145 S4 1.68 131 P4 0.45 166 
F5 1.68 143 S5 1.88 129 P5 0.51 164 
F6 2.10 140 S6 2.33 125 P6 0.63 162 
F7 1.84 152 S7 2.06 136 P7 0.48 166 
F8 2.05 150 S8 2.27 134 P8 0.55 165 
F9 2.55 145 S9 2.84 131 P9 0.68 163 
 
SS= Saturation solubility in Mg/mL 
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Aliquots were withdrawn at predetermined time 
intervals, analyzed by UV-visible spectrop-
hotometric method and cumulative percentage 
release of drug was recorded after one hour. 
 
RESULTS AND DISCUSSIONS 
Solid dispersions of Modafinil were 
prepared successfully by melting & solvent 
evaporation method and compared with 
physical mixtures of drug and carriers. All the 
prepared formulations were evaluated for 
saturation solubility & melting point; and the 
data of composition and evaluations of all the 
formulations were recorded in table I and table 
II. 
Batch S6 was selected after comparing 
the saturation solubility, formulated in tablet 
dosage form and extensively evaluated for in 
vitro dissolution and stability study. Tablet 
containing batch P6 and pure drug were also 
prepared and evaluated to get better 
comparison of the data. 
All the three tablet batches were 
characterised for melting point, saturation 
solubility and in vitro drug dissolution, as 
recorded in table IV, to understand stability of 
the formulations. 
By formulating solid dispersion of 
modafinil, the water solubility of pure drug was 
increased by 6 to 45 folds and melting point 
was reduced by 0 to 33 % in different batches, 
which suggested the conversion of crystalline 
form to amorphous form, which was then 
confirmed by DSC (Fig. 1) and XRD (Fig. 2) 
study. While comparing different carriers, PEG 
6000 was found to have higher potential to 
enhance the water solubility of modafinil by 
melting method. Hence, batch S6 showing 
maximum solubility enhancement was selected 
for extensive characterisation and compared 
with batch P6, as it is physical mixture of drug 
and PEG 8000 in the same proportion.  
DSC thermogram of pure drug has 
shown very sharp melting endotherm at 166° 
C-171° C for melting and an exotherm at 174° 
C-190° C due to its decomposition. DSC 
thermogram of PEG 6000 has given a sharp 
endotherm at 59° C-62° C for melting. Solid 
dispersions batch S6 (drug:PEG6000 at 1:4 
proportion by melting method) has given a 
sharp endotherm at 59° C-63° C that suggested 
that melting peak of drug was absent and 
melting point of the formulation was near to 
that of PEG 6000. Hence the DSC study also 
suggested alteration in state of the drug which 
supported the amorphisation of drug that led to 
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It was observed in the XRD study that 
pure drug is crystalline in nature showing at 
least three intense peaks along with several 
small to intermediate peaks in the spectra and 
pure carrier PEG 6000 is semi crystalline in 
nature showing two intense peaks in the 
spectra, but solid dispersion has no any intense 
peaks and showing only few peaks with lesser 
intensity as compared to pure drug  and carrier. 
Hence this study confirmed that was converted 
in amorphous state in solid dispersion batch S6 
which led to solubility enhancement. In spectra 
of physical mixture batch P6, reduction of 
number of peaks as well as intensity of peaks 
was observed which confirmed only partial 
conversion of crystalline form to amorphous 
form.   
In the present study, it was observed that 
as the proportion of hydrophilic carriers was 
increased, the solubility also increased which 
might be due to the improved wetting of drug 
particles by carrier as the particle surface 
rendered hydrophilic after coating by PEGs. 
Higher solubility enhancement was observed 
with PEG 6000 than PEG 2000 & PEG 10000 
due to some unknown cause but might be due 
to the similar melting behavior and crystalline 
properties which led to perfect solution of drug 
into carrier.  
Modafinil is slightly soluble in water 
(Jacobs et al., 2002) and its hydrophobic 
property prevented the powder surface from 
contacting the dissolution medium. In contrast, 
the dissolution rate of modafinil from batch 
TS6 was significantly higher than that of batch 
TP6 & batch CT. The results indicated that 
TS6 exhibited 92.79 % drug dissolution in 60 
minutes as compared to only 57.93 % & 46.34 
% from batch TP6 & batch CT respectively. 
The hydrophilic properties of PEG 6000 
probably led to greater wetting and increased 
surface available for dissolution by reducing 
interfacial tension between the hydrophobic 
drug and the dissolution medium. 
 
 
Figure 2. X-ray diffraction spectra of pure drug, PEG 6000, solid 
dispersion of drug:PEG 6000 at 1:4 ratio and physical mixture of 
drug:PEG 6000 at 1:4 ratio. 
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All the three tablets (batch TS6, TP6 & 
CT) were also evaluated for stability study for 
the duration of six months, where results of 
melting point, saturation solubility and one 
point in vitro drug dissolution study (% 
cumulative drug released after 60 minutes) were 
compared. It was observed that, melting point 
of solid dispersion (batch S6) was increase by 
9.16 % as compared to 1.22 % and 0.6 % in 
physical mixture (batch P6) and conventional 
tablet (batch CT) respectively, suggested 
stability problem in solid dispersion. Similar 
results were obtained in saturation solubility 
study as well as in vitro dissolution study, 
where significant change in these properties 
was observed which indicated poor stability of 
solid dispersion or the amorphous form. Hence 
stabilization of solid dispersion was needed to 
make this formulation strategy successful. 
   
CONCLUSION 
Solid dispersions of modafinil prepared 
with different polyethyleneglycols (PEG 2000, 
PEG 6000 & PEG 10000) by melting and 
solvent evaporation method resulted in 
increased saturation solubility of drug. Based 
on saturation solubility study of different solid 
dispersion, batch S6 was selected, as it has 
shown better results, and formulated into tablet 
along with batch P6 & pure drug; and evaluated 
for in vitro dissolution and stability study. As 
demonstrated by characterization of solid 
dispersion by DSC and XRD Study, a 
decreased crystallinity of modafinil as well as 
the surface morphology of the polymeric 
particles can explain the enhanced solubility 
and improved dissolution rate. Tablets 
containing solid dispersion (batch TS6) had 
drug dissolution profiles that were better than 
those of batch TP6 and batch CT which 
explains that solid dispersion can be utilized 
successfully to enhance the water solubility of 
poorly water soluble drug.  
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Table III. Composition of tablet containing pure drug, solid dispersion and physical mixture 
 
Amount in mg Tablet ingredients 
Batch TS6 Batch P6 Batch CT 
Drug* 500 500 100 
Carbopol 974 120 120 120 
Crosspovidone 24 24 24 
PVP K30 40 40 40 
Starch 80 80 80 
MCC 20 20 420 
Mg. Stearate 16 16 16 
Total  800 800 800 
 
*Solid dispersion and physical mixture are in proportion of drug:carrier 1:4, hence 500 mg of total 
formulation is equivalent to 100 mg of drug; batch TS6, TP6 and CT are coded for tablet of batch S6, batch 
P6 and convention tablet respectively. 
 
Table IV. Data of stability study conducted for six months 
 
Melting point Saturation solubility % CDR 60 Batches 
0m 6m % d 0m 6m % d 0m 6m % d 
S6/TS6* 119 131 9.16 2.58 1.86 27.91 92.79 67.04 27.75 
P6/TP6* 162 164 1.22 0.62 0.60 3.23 57.93 51.24 11.69 
drug/CT* 166 165 0.60 0.067 0.065 2.99 46.34 43.55 6.02 
 
% CDR 60= Cumulative percentage drug release after 60 minutes; % d= percentage difference; melting 
point and saturation solubility data is that of batch S6, P6 & pure drug; and %  CDR 60 data is of batch TS6, 
TP6 & CT. 
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